Boston, MA, United States of America

Wen Han

This inventor holds 4 USPTO granted patents and 3 published patent applications. Top assignees: Dicerna Pharmaceuticals, Inc., Novo Nordisk A/s. Active years: 2023-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wen Han. Retrieved from https://idiyas.com/inventor/wen-han-u3is356w

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 4.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Inventor Wen Han

Introduction

Wen Han is a notable inventor based in Boston, MA (US), recognized for her contributions to the field of biotechnology. With a total of 4 patents, she has made significant strides in developing methods and compositions that address critical health issues.

Latest Patents

Wen Han's latest patents focus on compositions and methods for inhibiting LPA expression. These patents detail oligonucleotides that inhibit apolipoprotein(a) (LPA) expression. The compositions provided are particularly useful in treating diseases, disorders, and conditions associated with LPA expression.

Career Highlights

Throughout her career, Wen Han has worked with prominent companies in the biotechnology sector, including Dicerna Pharmaceuticals, Inc. and Novo Nordisk A/S. Her work in these organizations has contributed to advancements in therapeutic solutions.

Collaborations

Wen Han has collaborated with esteemed colleagues such as Henryk T Dudek and Bob Dale Brown, enhancing her research and development efforts.

Conclusion

Wen Han's innovative work and patents in biotechnology demonstrate her commitment to improving health outcomes through scientific research. Her contributions continue to influence the field significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…